Stratos Wealth Partners LTD. Buys 1,288 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Stratos Wealth Partners LTD. increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 14,470 shares of the exchange traded fund’s stock after buying an additional 1,288 shares during the period. Stratos Wealth Partners LTD.’s holdings in SPDR S&P Biotech ETF were worth $1,620,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. CNB Bank bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $31,000. Valeo Financial Advisors LLC raised its stake in SPDR S&P Biotech ETF by 289.6% in the 2nd quarter. Valeo Financial Advisors LLC now owns 300 shares of the exchange traded fund’s stock worth $34,000 after purchasing an additional 223 shares in the last quarter. TCI Wealth Advisors Inc. acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth about $35,000. Verus Capital Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter worth about $36,000. Finally, Lenox Wealth Management Inc. acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth about $42,000.

Shares of SPDR S&P Biotech ETF stock opened at $109.33 on Friday. SPDR S&P Biotech ETF has a twelve month low of $62.94 and a twelve month high of $121.06. The company has a 50-day simple moving average of $111.77 and a two-hundred day simple moving average of $96.63.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: What is a Leveraged Buyout (LBO)?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.